Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
ICRG0201
Phase 2 small_molecule active
Quick answer
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) for Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active